Splitting times of doubly quantized vortices in dilute Bose-Einstein condensates

Recently, the splitting of a topologically created doubly quantized vortex into two singly quantized vortices was experimentally investigated in dilute atomic cigar-shaped Bose-Einstein condensates [Y. Shin et al., Phys. Rev. Lett. 93, 160406 (2004)]. In particular, the dependency of the splitting time on the peak particle density was studied. We present results of theoretical simulations which closely mimic the experimental set-up. Contrary to previous theoretical studies, claiming that thermal excitations are the essential mechanism in initiating the splitting, we show that the combination of gravitational sag and time dependency of the trapping potential alone suffices to split the doubly quantized vortex in time scales which are in good agreement with the experiments. We also study the dynamics of the resulting singly quantized vortices which typically intertwine--especially, a peculiar vortex chain structure appears for certain parameter values.Comment: 5 pages, 5 figure

Environmental responsibility in hospital care : findings from a qualitative study

Objective: To identify the key elements of environmental responsibility in hospital care and the stakeholders involved. Background: Hospital care causes a significant global environmental burden, which threatens human health and wellbeing. Environmental responsibility has been identified as an essential part of patient care with regard to health promotion and wellbeing of humans, but it has often been regarded as a secondary issue in hospitals. In addition, the lack of organizational structures and administrative as well as managerial support inhibit the promotion of environmental responsibility in hospitals. Methods: We used a qualitative study with semi-structured interviews and document analysis. Our data was drawn from the environmental managers of five Finnish university hospitals and documents on their environmental programs. Results: We found that the aim of environmental responsibility in hospital care was to avoid unnecessary emissions, and that it was guided by the authorities and by ethical values. It included targets for sustainable use of material, electricity, water and transport. Environmental responsibility required the involvement of several stakeholders, including administrators, environmental manager, immediate leaders, environmental support people, staff and patients. Implementation of environmental responsibility was promoted by collaboration, education, diverse initiatives to motivate staff, and continuously developing practices. Conclusions: Environmental responsibility extended throughout a hospital organization. Staff was in a key position to implement it, but they needed versatile organizational support, including education, clear procedures, defined roles, and a motivational culture and facilities. Implications for hospital management: This study yields new knowledge that will provide information for the development of organisational structures with respect to environmental responsibility in hospital care. Keywords: Environmental manager, Environmental program, Environmental responsibility, Hospital, Key informan

Non-Abelian magnetic monopole in a Bose-Einstein condensate

Recently, an effective non-Abelian magnetic field with a topology of a monopole was shown to emerge from the adiabatic motion of multilevel atoms in spatially varying laser fields [J. Ruseckas et al., Phys. Rev. Lett. 95, 010404 (2005)]. We study this monopole in a Bose-Einstein condensate (BEC) of degenerate dressed states and find that the topological charge of the pseudospin cancels the monopole charge resulting in a vanishing gauge invariant charge. As a function of the laser wavelength, different stationary states are classified in terms of their effect to the monopole part of the magnetic field and a cross-over to vortex ground state is observed.Comment: 5 pages, 1 color figure; v2 modified according to referees' suggestions, some typos corrected; v3 minor modifications, published versio

Ground-State Dirac Monopole

We show theoretically that a monopole defect, analogous to the Dirac magnetic monopole, may exist as the ground state of a dilute spin-1 Bose-Einstein condensate. The ground-state monopole is not attached to a single semi-infinite Dirac string, but forms a point where the circulation of a single vortex line is reversed. Furthermore, the three-dimensional dynamics of this monopole defect are studied after the magnetic field pinning the monopole is removed and the emergence of antimonopoles is observed. Our scheme is experimentally realizable with the present-day state of the art

Internet as a source of medicines information (MI) among frequent internet users

Background: The internet is widely and increasingly used to search for health information. Previous studies have focused mainly on health information on the internet and not specifically on medicines information (MI). Objectives: The aim of this study was to explore the internet as a source of MI compared to other sources of MI; to identify those who use the internet as a source of MI; and to describe patterns of use of the internet as a source of MI. Methods: A cross-sectional design employed a web-based questionnaire posted by patients' and other organizations as well as pharmacies on their websites during six weeks in the beginning of 2014. Logistic regression analysis was used to assess associations of background variables to the use of different MI sources. Results: The most frequently used MI sources among respondents (n = 2489) were package leaflets (90%), pharmacists (83%), physicians (72%), and the internet (68%). According to a multivariate analysis, internet use for MI was associated with female gender, age <65 years, higher education, daily use of the internet, and continuous use of vitamins or herbals. MI was most commonly searched from a Finnish health portal (56%) and websites of pharmacies (41%). Of the respondents, nearly half (43%) used search engines to find information from the internet. The names of the medicinal product, symptom or disease were the most commonly used search terms. Conclusions: Well-educated, young women tend to search MI on the internet. Health care professionals should discuss reliable MI websites and tools that can help patients evaluate the reliability of information.Peer reviewe

Comparison of two rebound tonometers in healthy horses

Objective: To obtain a reference range for evaluation of intraocular pressure (IOP) in horses using Tonovet Plus (R), to compare the IOP readings obtained with Tonovet (R) and Tonovet Plus (R), and to evaluate the repeatability of readings. Animals studied and Procedures: Intraocular pressure of 30 client-owned horses (60 eyes) with no signs of illness or ocular disease was evaluated using Tonovet (R) and Tonovet Plus (R) rebound tonometers. Horses' mean age was 10.7 (range 6-17) years. Triplicate measurements were performed without using sedatives or local anesthetics, with minimal restraint. Results: Calculated reference intervals (the CLSI robust method) were 14.4-27.2 mmHg for Tonovet (R) and 16.0-26.1 mmHg for Tonovet Plus (R). Mean values (+/- standard deviation, SD [+/- coefficient of variation, CV]) obtained with Tonovet Plus (R)(21.6 +/- 2.45 mmHg [11.3%]) were on average 0.6 mmHg higher than with Tonovet (R)(21.0 +/- 3.14 mmHg [15.0%]), and a negligible statistical difference between the devices was found using the paired sample t test (P = .049). The correlation coefficient for the averaged triplicate measurements was 0.73. The average CV was 4.6% and 4.4% for Tonovet (R) and Tonovet Plus (R), respectively. Conclusions: The repeatability of measurements was very good with both devices. The readings between the two devices differed statistically significantly, but the correlation was considered good and the variation was numerically small, and thus, the difference was considered clinically irrelevant. When monitoring disease process or treatment response in an individual patient, repeated readings are best performed using a similar device to avoid false interpretation of results.Peer reviewe

Pleolipoviridae, a newly proposed family comprising archaeal pleomorphic viruses with single-stranded or double-stranded DNA genomes

Viruses infecting archaea show a variety of virion morphotypes, and they are currently classified into more than ten viral families or corresponding groups. A pleomorphic virus morphotype is very common among haloarchaeal viruses, and to date, several such viruses have been isolated. Here, we propose the classification of eight such viruses and formation of a new family, Pleolipoviridae (from the Greek pleo for more or many and lipos for lipid), containing three genera, Alpha-, Beta-, and Gammapleolipovirus. The proposal is currently under review by the International Committee on Taxonomy of Viruses (ICTV). The members of the proposed family Pleolipoviridae infect halophilic archaea and are nonlytic. They share structural and genomic features and differ from any other classified virus. The virion of pleolipoviruses is composed of a pleomorphic membrane vesicle enclosing the genome. All pleolipoviruses have two major structural protein species, internal membrane and spike proteins. Although the genomes of the pleolipoviruses are single- or double-stranded, linear or circular DNA molecules, they share the same genome organization and gene synteny and show significant similarity at the amino acid level. The canonical features common to all members of the proposed family Pleolipoviridae show that they are closely related and thus form a new viral family.Peer reviewe

Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment?

Changes in the tumor microenvironment (TME) can trigger the activation of otherwise non-malignant cells to become highly aggressive and motile. This is evident during initial tumor growth when the poor vascularization in tumors generates hypoxic regions that trigger the latent embryonic program, epithelial-to-mesenchymal transition (EMT), in epithelial carcinoma cells (e-cars) leading to highly motile mesenchymal-like carcinoma cells (m-cars), which also acquire cancer stem cell properties. After that, specific bidirectional interactions take place between m-cars and the cellular components of TME at different stages of metastasis. These interactions include several vicious positive feedback loops in which m-cars trigger a phenotypic switch, causing normal stromal cells to become pro-tumorigenic, which then further promote the survival, motility, and proliferation of m-cars. Accordingly, there is not a single culprit accounting for metastasis. Instead both m-cars and the TME dynamically interact, evolve and promote metastasis. In this review, we discuss the current status of the known interactions between m-cars and the TME during different stages of metastasis and how these interactions promote the metastatic activity of highly malignant m-cars by promoting their invasive mesenchymal phenotype and CSC properties. (C) 2016 Elsevier Ireland Ltd. All rights reserved

Effect of Inhaled Xenon on Cerebral White Matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial

IMPORTANCE: Evidence from preclinical models indicates that xenon gas can prevent the development of cerebral damage after acute global hypoxic-ischemic brain injury but, thus far, these putative neuroprotective properties have not been reported in human studies. OBJECTIVE: To determine the effect of inhaled xenon on ischemic white matter damage assessed with magnetic resonance imaging (MRI). DESIGN, SETTING, AND PARTICIPANTS: A randomized single-blind phase 2 clinical drug trial conducted between August 2009 and March 2015 at 2 multipurpose intensive care units in Finland. One hundred ten comatose patients (aged 24-76 years) who had experienced out-of-hospital cardiac arrest were randomized. INTERVENTIONS: Patients were randomly assigned to receive either inhaled xenon combined with hypothermia (33°C) for 24 hours (n = 55 in the xenon group) or hypothermia treatment alone (n = 55 in the control group). MAIN OUTCOMES AND MEASURES: The primary end point was cerebral white matter damage as evaluated by fractional anisotropy from diffusion tensor MRI scheduled to be performed between 36 and 52 hours after cardiac arrest. Secondary end points included neurological outcome assessed using the modified Rankin Scale (score 0 [no symptoms] through 6 [death]) and mortality at 6 months. RESULTS: Among the 110 randomized patients (mean age, 61.5 years; 80 men [72.7%]), all completed the study. There were MRI data from 97 patients (88.2%) a median of 53 hours (interquartile range [IQR], 47-64 hours) after cardiac arrest. The mean global fractional anisotropy values were 0.433 (SD, 0.028) in the xenon group and 0.419 (SD, 0.033) in the control group. The age-, sex-, and site-adjusted mean global fractional anisotropy value was 3.8% higher (95% CI, 1.1%-6.4%) in the xenon group (adjusted mean difference, 0.016 [95% CI, 0.005-0.027], P = .006). At 6 months, 75 patients (68.2%) were alive. Secondary end points at 6 months did not reveal statistically significant differences between the groups. In ordinal analysis of the modified Rankin Scale, the median (IQR) value was 1 (1-6) in the xenon group and 1 (0-6) in the control group (median difference, 0 [95% CI, 0-0]; P = .68). The 6-month mortality rate was 27.3% (15/55) in the xenon group and 34.5% (19/55) in the control group (adjusted hazard ratio, 0.49 [95% CI, 0.23-1.01]; P = .053). CONCLUSIONS AND RELEVANCE: Among comatose survivors of out-of-hospital cardiac arrest, inhaled xenon combined with hypothermia compared with hypothermia alone resulted in less white matter damage as measured by fractional anisotropy of diffusion tensor MRI. However, there was no statistically significant difference in neurological outcomes or mortality at 6 months. These preliminary findings require further evaluation in an adequately powered clinical trial designed to assess clinical outcomes associated with inhaled xenon among survivors of out-of-hospital cardiac arrest. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00879892